Mashidori Tomoko, Shirataki Hiromichi, Kamai Takao, Nakamura Fumihiko, Yoshida Ken-Ichiro
Department of Urology, Dokkyo Medical University, Mibu, Tochigi, Japan.
Biomed Res. 2011 Apr;32(2):103-10. doi: 10.2220/biomedres.32.103.
Intracellular vesicle trafficking is the principal transportation system in eukaryotic cells, and is considered to be involved in a variety of processes related to cell proliferation. A protein named alpha-taxilin has been identified as a binding partner of the syntaxin family, which coordinates intracellular vesicle trafficking. To clarify the role of alpha-taxilin in renal cell carcinoma (RCC), we investigated alpha-taxilin protein expression in clear cell RCC tissues. We analyzed alphataxilin protein in matched sets of tumor and non-tumor tissues from the surgical specimens of 52 Japanese RCC patients by Western blotting. We also studied the relation between alpha-taxilin protein expression in tumor tissues and various clinicopathological features. The alpha-taxilin protein level was higher in tumor tissues than in non-tumor tissues (P < 0.05). Increased expression of alpha-taxilin protein in primary tumors was related to local invasion (P < 0.001), pathological vessel invasion (P < 0.001), and metastasis (P < 0.0001). Kaplan-Meier plots of survival for patients with low versus high alpha-taxilin expression revealed that high expression in tumor tissues was associated with shorter overall survival in all patients (P < 0.05) and with shorter disease-free survival in patients without metastasis (P < 0.01). These findings suggest that alpha-taxilin influences the metastatic and invasive potential of RCC.
细胞内囊泡运输是真核细胞中的主要运输系统,被认为参与了与细胞增殖相关的多种过程。一种名为α-微管蛋白结合蛋白的蛋白质已被鉴定为Syntaxin家族的结合伴侣,它协调细胞内囊泡运输。为了阐明α-微管蛋白结合蛋白在肾细胞癌(RCC)中的作用,我们研究了透明细胞RCC组织中α-微管蛋白结合蛋白的表达。我们通过蛋白质免疫印迹法分析了52例日本RCC患者手术标本中肿瘤组织和非肿瘤组织配对样本中的α-微管蛋白结合蛋白。我们还研究了肿瘤组织中α-微管蛋白结合蛋白表达与各种临床病理特征之间的关系。肿瘤组织中α-微管蛋白结合蛋白水平高于非肿瘤组织(P < 0.05)。原发性肿瘤中α-微管蛋白结合蛋白表达增加与局部侵犯(P < 0.001)、病理血管侵犯(P < 0.001)和转移(P < 0.0001)有关。对α-微管蛋白结合蛋白低表达和高表达患者的生存进行Kaplan-Meier分析显示,肿瘤组织中高表达与所有患者的总生存期缩短(P < 0.05)以及无转移患者的无病生存期缩短(P < 0.01)相关。这些发现表明α-微管蛋白结合蛋白影响RCC的转移和侵袭潜能。